Dr. Corinna Fiorotti

Corinna Fiorotti obtained her Ph.D. in Microbiology and Immunology in 1999 from the University of New Hampshire where she investigated bacterial pathogenesis of Legionnaires’ disease. She attended Harvard Medical School to complete a post-doctoral fellowship in Molecular Genetics where she was awarded several NIH grants to investigate polysaccharide genetics of Bacteroides fragilis. Her work was featured as a cover story in the journal Nature. She was promoted to the faculty at Harvard continuing her research in bacterial genetics and immune evasion and teaching medical students.

In 2003 she joined Eyetech Pharmaceuticals and investigated the mechanism of disease in age-related macular degeneration and was involved in the approval of Macugen®. In 2005 she joined Pfizer and was responsible for developing cell-based assays for the detection of neutralizing antibodies, ADA and PK assays for both clinical and preclinical support in a GLP laboratory. She joined BioAgilytix labs in 2015 as the Business Development Director and was promoted to Scientific Officer and Key Accounts Director in 2019.